ISU ABXIS revenue for the last year amounted to 54.30 B KRW, the most of which — 54.31 B KRW — came from its highest performing source at the moment, Treatment, the year earlier bringing 41.17 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought ISU ABXIS 24.19 B KRW, and the year before that — 22.25 B KRW.